Alcohol-sourced acetate impairs T cell function by promoting cortactin acetylation.

Immunology Molecular biology

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
21 Jul 2023
Historique:
received: 18 10 2022
revised: 28 02 2023
accepted: 23 06 2023
medline: 24 7 2023
pubmed: 24 7 2023
entrez: 24 7 2023
Statut: epublish

Résumé

Alcohol is among the most widely consumed dietary substances. Excessive alcohol consumption damages the liver, heart, and brain. Alcohol also has strong immunoregulatory properties. Here, we report how alcohol impairs T cell function via acetylation of cortactin, a protein that binds filamentous actin and facilitates branching. Upon alcohol consumption, acetate, the metabolite of alcohol, accumulates in lymphoid organs. T cells exposed to acetate, exhibit increased acetylation of cortactin. Acetylation of cortactin inhibits filamentous actin binding and hence reduces T cell migration, immune synapse formation and activation. While mutated, acetylation-resistant cortactin rescues the acetate-induced inhibition of T cell migration, primary mouse cortactin knockout T cells exhibited impaired migration. Acetate-induced cytoskeletal changes effectively inhibited activation, proliferation, and immune synapse formation in T cells

Identifiants

pubmed: 37485352
doi: 10.1016/j.isci.2023.107230
pii: S2589-0042(23)01307-X
pmc: PMC10362326
doi:

Types de publication

Journal Article

Langues

eng

Pagination

107230

Informations de copyright

© 2023 The Author(s).

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):458-63
pubmed: 25453080
Dev Cell. 2007 Aug;13(2):161-2
pubmed: 17681125
Science. 2009 Aug 14;325(5942):834-40
pubmed: 19608861
J Biomech. 2010 Jan 5;43(1):9-14
pubmed: 19913792
Front Immunol. 2015 Nov 18;6:586
pubmed: 26635800
Nat Commun. 2020 Apr 24;11(1):1998
pubmed: 32332730
Am J Pathol. 2020 May;190(5):958-967
pubmed: 32084363
J Exp Med. 1995 Feb 1;181(2):577-84
pubmed: 7836913
Oncogene. 2001 Oct 1;20(44):6418-34
pubmed: 11607842
Methods. 2017 Feb 15;115:80-90
pubmed: 27713081
Nat Rev Immunol. 2003 Nov;3(11):867-78
pubmed: 14668803
Nucleic Acids Res. 2016 Jan 4;44(D1):D447-56
pubmed: 26527722
Alcohol. 1985 Jul-Aug;2(4):623-6
pubmed: 4026986
Blood. 2012 Mar 15;119(11):2443-51
pubmed: 22246031
Mol Cell Proteomics. 2012 Apr;11(4):M111.010587
pubmed: 22186715
Nature. 2019 Oct;574(7780):717-721
pubmed: 31645761
Cell. 2014 Jul 31;158(3):492-505
pubmed: 25083865
Nat Rev Immunol. 2021 Sep;21(9):582-596
pubmed: 33627851
Sci Adv. 2017 Jun 21;3(6):e1603032
pubmed: 28691087
Trends Cell Biol. 2019 Sep;29(9):695-703
pubmed: 31160120
Nat Rev Mol Cell Biol. 2006 Oct;7(10):713-26
pubmed: 16990851
N Engl J Med. 2000 Oct 5;343(14):1020-34
pubmed: 11018170
Nat Rev Immunol. 2009 Mar;9(3):153-61
pubmed: 19240755
Cell. 2018 Oct 4;175(2):502-513.e13
pubmed: 30245009
Front Cell Dev Biol. 2020 Oct 21;8:591348
pubmed: 33195256
Lancet. 2009 Feb 7;373(9662):492-501
pubmed: 19168210
Curr Biol. 2005 Jul 26;15(14):1276-85
pubmed: 16051170
J Basic Microbiol. 2009 Feb;49(1):82-91
pubmed: 19206143
Int Immunopharmacol. 2013 May;16(1):72-8
pubmed: 23541634
Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):18036-41
pubmed: 23071319
PLoS Comput Biol. 2016 Mar 18;12(3):e1004818
pubmed: 26990103
Front Immunol. 2019 Oct 25;10:2512
pubmed: 31708928
Nutrients. 2021 Apr 16;13(4):
pubmed: 33923766
J Cell Sci. 2007 Mar 1;120(Pt 5):723-30
pubmed: 17314246
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Immunity. 2006 Jun;24(6):741-752
pubmed: 16782030
Trends Cell Biol. 2018 Feb;28(2):79-98
pubmed: 29162307
Cell Metab. 2015 Jun 2;21(6):805-21
pubmed: 26039447
Autoimmunity. 2010 Feb;43(1):64-75
pubmed: 20001423
Alcohol Res Health. 2006;29(4):245-54
pubmed: 17718403
Eur J Cell Biol. 2011 Feb-Mar;90(2-3):172-80
pubmed: 20656375
Immunol Rev. 2013 Nov;256(1):5-9
pubmed: 24117809
J Neurosci. 2020 Feb 12;40(7):1389-1404
pubmed: 31911458
Dev Cell. 2016 Sep 26;38(6):571-3
pubmed: 27676427
Nat Cell Biol. 2001 Mar;3(3):259-66
pubmed: 11231575
J Cell Biol. 2020 Dec 7;219(12):
pubmed: 33044556
Cytoskeleton (Hoboken). 2017 Aug;74(8):283-296
pubmed: 28445605
Nat Methods. 2017 Jan;14(1):53-56
pubmed: 27869816
Nat Immunol. 2017 May;18(5):552-562
pubmed: 28346408
Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):258-63
pubmed: 17185416
Gut. 2019 Jul;68(7):1311-1322
pubmed: 30121625
Front Cell Dev Biol. 2018 Sep 19;6:116
pubmed: 30283780
Alcohol Clin Exp Res. 1985 Sep-Oct;9(5):468-71
pubmed: 3904514
Alcohol Alcohol. 1999 Nov-Dec;34(6):830-41
pubmed: 10659718
Nat Methods. 2009 May;6(5):359-62
pubmed: 19377485
Front Cell Infect Microbiol. 2021 Dec 02;11:785833
pubmed: 34926327
Oncogene. 2009 Jan 22;28(3):445-60
pubmed: 18850005
Immunity. 2004 Apr;20(4):417-28
pubmed: 15084271
Blood. 2012 Mar 15;119(11):2579-89
pubmed: 22262760
Proc Natl Acad Sci U S A. 2015 Sep 29;112(39):12151-6
pubmed: 26371316
Neurosci Biobehav Rev. 2019 Nov;106:112-121
pubmed: 29738795
J Allergy Clin Immunol. 2015 May;135(5):1228-39
pubmed: 25458911
Mol Cell. 2007 Jul 20;27(2):197-213
pubmed: 17643370
Cell Rep. 2019 Mar 19;26(12):3369-3379.e5
pubmed: 30893608
Clin Immunol. 2016 Jan;162:58-73
pubmed: 26604012
Proteomes. 2015 Nov 12;3(4):411-423
pubmed: 28248277

Auteurs

Vugar Azizov (V)

Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Michel Hübner (M)

Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Michael Frech (M)

Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Jörg Hofmann (J)

Division of Biochemistry, Department of Biology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.

Marketa Kubankova (M)

Max Planck Institute for the Science of Light & Max Planck Zentrum für Physik und Medizin, Erlangen, Germany.

Dennis Lapuente (D)

Institute of Clinical and Molecular Virology, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Matthias Tenbusch (M)

Institute of Clinical and Molecular Virology, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Jochen Guck (J)

Max Planck Institute for the Science of Light & Max Planck Zentrum für Physik und Medizin, Erlangen, Germany.

Georg Schett (G)

Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Mario M Zaiss (MM)

Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Classifications MeSH